---
title: "Autobio released its first-quarter performance, with a net profit attributable to the parent company of 270 million yuan, a year-on-year decrease of 16.76%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236376070.md"
description: "According to the Zhitong Finance APP, Autobio disclosed its first-quarter report for 2025, showing that the company achieved revenue of 996 million yuan, a year-on-year decrease of 8.56%; net profit attributable to the parent company was 270 million yuan, a year-on-year decrease of 16.76%; and net profit excluding non-recurring gains and losses was 257 million yuan, a year-on-year decrease of 18.19%. The basic earnings per share were 0.47 yuan"
datetime: "2025-04-17T09:01:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236376070.md)
  - [en](https://longbridge.com/en/news/236376070.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236376070.md)
generator: "portal-rs"
---

# Autobio released its first-quarter performance, with a net profit attributable to the parent company of 270 million yuan, a year-on-year decrease of 16.76%

According to the Zhitong Finance APP, Autobio (603658.SH) disclosed its first-quarter report for 2025, showing that the company achieved revenue of 996 million yuan, a year-on-year decrease of 8.56%; net profit attributable to the parent company was 270 million yuan, a year-on-year decrease of 16.76%; and net profit excluding non-recurring gains and losses was 257 million yuan, a year-on-year decrease of 18.19%. Basic earnings per share were 0.47 yuan

### Related Stocks

- [603658.CN](https://longbridge.com/en/quote/603658.CN.md)

## Related News & Research

- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)
- [Cleo Diagnostics to Commence Analytical Validation of Pre-Surgical Ovarian Cancer Blood Test](https://longbridge.com/en/news/297848437.md)
- [Generational Group Advises Cantor BioConnect in its Sale to Prairie Capital](https://longbridge.com/en/news/297685099.md)
- [09:29 ETResonant Clinical Solutions Expands Advanced-Therapy and Cryogenic Storage Capabilities with Acquisition of Creapharm Bioservices](https://longbridge.com/en/news/297922524.md)
- [11:00 ETCovationBio's Xatryx® Mass Production On Spec, to Debut First Non‑Food Bio‑Based Athletic Insole at NW Materials Show in the U.S.](https://longbridge.com/en/news/297804526.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**